Comparison of CMF (Cyclophosphamide, Methotrexate, and 5-Fluorouracil) With a Rotational Crossing and a Sequential Intensification Regimen in Advanced Breast Cancer
Giorgio Cocconi, Paola Buzzi(Aims Community College), P. Anastasi(Aims Community College), Luigi Acito, Giancarlo Bisagni, A.M. Mosconi, Antonio Frassoldati(Italian Oncology Group of Clinical Research), A Carpi(Aims Community College), A. Borrini(Aims Community College), Mariangela Bella(Aims Community College), Francesco Di Costanzo
Cited by 10
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368